Ubs Group Ag Atai Life Sciences N.V. Transaction History
Ubs Group Ag
- $528 Billion
- Q1 2025
A detailed history of Ubs Group Ag transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Ubs Group Ag holds 5,535,482 shares of ATAI stock, worth $22.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,535,482
Previous 1,939,108
185.47%
Holding current value
$22.9 Million
Previous $2.58 Million
191.9%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding ATAI
# of Institutions
106Shares Held
23.4MCall Options Held
351KPut Options Held
170K-
Morgan Stanley New York, NY3.29MShares$13.6 Million0.0% of portfolio
-
Pale Fire Capital Se Prague, 2N2.59MShares$10.7 Million0.42% of portfolio
-
Davidson Kempner Capital Management LP New York, NY1.41MShares$5.84 Million0.07% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$5.4 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.14MShares$4.69 Million0.0% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $685M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...